Australia markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
29.78-0.72 (-2.36%)
At close: 04:00PM EDT
30.00 +0.22 (+0.74%)
After hours: 05:11PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-107,296
-29,725
9,349
-203,674
-72,148
Depreciation & amortisation
3,283
2,957
1,527
1,193
882
Stock-based compensation
36,555
34,649
30,611
28,915
6,764
Change in working capital
79,690
7,381
-12,557
32,625
21,216
Accounts receivable
65,426
-29,300
603
-1,242
54
Accounts payable
-10,161
-2,238
-3,112
-769
4,812
Other working capital
9,765
-21,000
24,267
-138,449
-44,603
Other non-cash items
-
502
2,173
6,990
162
Net cash provided by operating activities
12,215
-18,099
31,993
-135,043
-42,861
Cash flows from investing activities
Investments in property, plant and equipment
-2,450
-2,901
-7,726
-3,406
-1,742
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
-
0
Net cash used for investing activities
-2,450
-2,901
-7,726
-3,406
-1,742
Cash flows from financing activities
Debt repayment
-20,000
-47,364
-5,000
0
-
Common stock issued
-
609
411
515
423,819
Net cash used provided by (used for) financing activities
5,465
-24,087
-2,859
48,016
436,145
Net change in cash
15,230
-45,087
21,408
-90,433
391,542
Cash at beginning of period
330,051
393,977
372,569
463,002
71,460
Cash at end of period
345,281
348,890
393,977
372,569
463,002
Free cash flow
Operating cash flow
12,215
-18,099
31,993
-135,043
-42,861
Capital expenditure
-2,450
-2,901
-7,726
-3,406
-1,742
Free cash flow
9,765
-21,000
24,267
-138,449
-44,603